Stifel has recently initiated Cullinan Therapeutics Inc (CGEM) stock to Buy rating, as announced on May 1, 2024, according to Finviz. Earlier, on April 15, 2024, William Blair had initiated the stock ...

After buying a Rolls-Royce Cullinan for his five-year-old daughter, this man made an equally astonishing purchase at an ...

Nicholas Cullinan, the new director of the British Museum, has announced a groundbreaking $1.3 billion transformation plan, ...

BTIG analyst Julian Harrison maintained a Buy rating on Cullinan Management (CGEM – Research Report) yesterday and set a price target of ...

Wedbush analyst Robert Driscoll initiated coverage with a Buy rating on Cullinan Management (CGEM – Research Report) today and set a ...

The Human Research Ethics Committee (HREC) in Australia has granted clearance for Cullinan Therapeutics to commence an ...

Cullinan Therapeutics Inc (CGEM) stock saw a decline, ending the day at $18.51 which represents a decrease of $-1.09 or -5.56% from the prior close of $19.6. The stock opened at $19.34 and touched a ...

PEORIA ( 25News Now) - A prominent developer has agreed to sell to the city government a Downtown Peoria high-rise, a vacant ...

The newly-evolved Rolls-Royce Cullinan Series II appeals to the discerning tastes of ultra-luxury SUV enthusiasts through ...

Rolls-Royce has unveiled the Cullinan Series II, marking a bold evolution of its renowned super-luxury SUV. This latest ...

Cullinan Therapeutics Inc. has submitted an IND application to the FDA to evaluate its CD19 x CD3 bispecific T-cell engager, CLN-978, for the treatment of systemic lupus erythematosus (SLE).

(nee Halaburt) Age 94, died peacefully at home on September 5, 2024. Beloved wife of the late John A. Cullinan. Devoted mother of Kathy (Dean) Mitchell, Susan (Chris) Lyons, Patty (Jim) Fahey, Pam ...